Formacyte has developed a patent-pending injection-free cellular implant which has the potential to enhance the survival of therapeutic cells to effectively manage insulin-dependent diabetes. After a simple under-skin insertion, the cells in our device can sense the blood glucose level and secrete insulin to provide injection-free, precise glucose control to diabetic recipients. Our device also protects the cells by encapsulating them in a hydrogel to shield them from immune attack without requiring immunosuppressant drugs.

Led by Prof. Dang Thuy Tram, consists of Dr. Chen Yang, Dr. Nguyen Tri Dang, Mr. Nam Tran and Ms. Chi Pham at NTU’s School of Chemistry, Chemical Engineering & Biotechnology and Mr Arnold Giovanni, an alumnus of Nanyang Business School.

Our team has won multiple national and international entrepreneurship awards such as Winner of Health category in the 2022 Prototype for Humanity showcase against top 100 global university teams and the Second Prize winner (Team Category) of the 2022 China-Asean Innovation and Entrepreneurship competition. Our other achievements include the second prize at the 2021 Society for Biomaterials Business Plan Competition (USA) and the second prize at the Singapore national grand final of the 15K entrepreneurship competition organized by MIT Club of Singapore.

For further enquiry, please contact Asst Prof DANG Thuy.